| 1 | 100706-81-8 | teomorfolin | teomorfolin | C13H17N5O4
| | |
| 2 | 15763-12-9 | N-allyladenosine | N-allyladenosine | C13H17N5O4
| | |
| 3 | 133766-26-4 | 2'-O-烯丙基腺苷 | 2'-O-Allyladenosine | C13H17N5O4
| | |
| 4 | | N-Cyclopropyladenosine | N-Cyclopropyladenosine | C13H17N5O4
| | |
| 5 | 77378-04-2 | N6-丙酰虫草素 | N6-Propionyl Cordycepin | C13H17N5O4
| | |
| 6 | 97374-48-6 | Adenosine, N-cyclopropyl- | Adenosine, N-cyclopropyl- | C13H17N5O4
| | |
| 7 | | N6-Propionyl Cordycepin-d5 | N6-Propionyl Cordycepin-d5 | C13H17N5O4
| Bases & Related Reagents;Carbohydrates & Derivatives;Heterocycles;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Nucleotides;Pharmaceuticals | |
| 8 | 120667-07-4 | 1,N(2)-propanodeoxyguanosine | 1,N(2)-propanodeoxyguanosine | C13H17N5O4
| | |
| 9 | 362-75-4 | 2',3'-异丙叉腺苷 | 2',3'-O-Isopropylideneadenosine | C13H17N5O4
| 核苷;原料;中间体;化学试剂;嘌呤核苷酸;化学生物学;医药中间体;有机化工原料;碳水化合物合成;医药、农药及染料中间体 | |
| 10 | 1377950-60-1 | 6-N-ACYL-6-N-甲基-2'-脱氧腺苷 | 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | C13H17N5O4
| | |
| 11 | 2349444-69-3 | Entecavir EP Impurity E (8-Methoxy Entecavir) | Entecavir EP Impurity E (8-Methoxy Entecavir) | C13H17N5O4
| | |
| 12 | 144987-76-8 | 1-ETHYL 4-PROPYL 2-(6-AMINO-9H-PURIN-9-YL)SUCCINATE | 1-ETHYL 4-PROPYL 2-(6-AMINO-9H-PURIN-9-YL)SUCCINATE | C13H17N5O4
| | |
| 13 | | 3'-(4-Methyl-1H-1,2,3-triazol-1-yl)-3'-deoxythymidine | 3'-(4-Methyl-1H-1,2,3-triazol-1-yl)-3'-deoxythymidine | C13H17N5O4
| | |
| 14 | 61785-52-2 | 4-Nitro-7-(4-propyl-1-piperazinyl)benzofurazane 1-oxide | 4-Nitro-7-(4-propyl-1-piperazinyl)benzofurazane 1-oxide | C13H17N5O4
| | |
| 15 | 4407-82-3 | 2,4-Bis[bis(hydroxymethyl)amino]-6-phenyl-1,3,5-triazine | 2,4-Bis[bis(hydroxymethyl)amino]-6-phenyl-1,3,5-triazine | C13H17N5O4
| | |
| 16 | | 3'-(4,5-Dimethyl-1H-1,2,3-triazol-1-yl)-2',3'-dideoxyuridine | 3'-(4,5-Dimethyl-1H-1,2,3-triazol-1-yl)-2',3'-dideoxyuridine | C13H17N5O4
| | |
| 17 | | 1-[3,4,5-Trimethoxybenzyl]-5-amino-1H-1,2,3-triazole-4-carboxamide | 1-[3,4,5-Trimethoxybenzyl]-5-amino-1H-1,2,3-triazole-4-carboxamide | C13H17N5O4
| | |
| 18 | 195442-56-9 | 4-Amino-2,6-dimethyl-8-(2'-deoxy-β-D-ribofuranosyl)-7(8H)-pteridone | 4-Amino-2,6-dimethyl-8-(2'-deoxy-β-D-ribofuranosyl)-7(8H)-pteridone | C13H17N5O4
| | |
| 19 | | PENTANE-2,3,4-TRIONE 3-{[4-(MORPHOLIN-4-YLCARBONYL)-1H-IMIDAZOL-5-YL]HYDRAZONE} | PENTANE-2,3,4-TRIONE 3-{[4-(MORPHOLIN-4-YLCARBONYL)-1H-IMIDAZOL-5-YL]HYDRAZONE} | C13H17N5O4
| | |
| 20 | | 1-(1,3-DIMETHYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)PIPERIDINE-4-CARBOXYLIC ACID | 1-(1,3-DIMETHYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)PIPERIDINE-4-CARBOXYLIC ACID | C13H17N5O4
| | |
| 21 | 107550-40-3 | 6H-Purin-6-one, 1,7-dihydro-2-[(tetrahydro-2-furanyl)amino]-7-[(tetrahydro-2-furanyl)oxy]- | 6H-Purin-6-one, 1,7-dihydro-2-[(tetrahydro-2-furanyl)amino]-7-[(tetrahydro-2-furanyl)oxy]- | C13H17N5O4
| | |
| 22 | | 2-[(1,3-DIMETHYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)AMINO]ETHYL CYCLOPROPANECARBOXYLATE | 2-[(1,3-DIMETHYL-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)AMINO]ETHYL CYCLOPROPANECARBOXYLATE | C13H17N5O4
| | |
| 23 | | N'-(5-hydroxy-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-7-yl)butanohydrazide | N'-(5-hydroxy-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-7-yl)butanohydrazide | C13H17N5O4
| | |